Cargando…
Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans
In the United States, Hepatocellular Carcinoma (HCC) incidence has tripled over the past two decades. The disease has disproportionately affected minority and disadvantaged populations. The purpose of this study was to examine the expression of SATB2 gene in HCC cells derived from African Americans...
Autores principales: | Yu, Wei, Roy, Sanjit K., Ma, Yiming, LaVeist, Thomas A., Shankar, Sharmila, Srivastava, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850930/ https://www.ncbi.nlm.nih.gov/pubmed/31602781 http://dx.doi.org/10.1111/jcmm.14652 |
Ejemplares similares
-
SATB2 is a novel biomarker and therapeutic target for cancer
por: Roy, Sanjit K., et al.
Publicado: (2020) -
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma
por: Thylur, Ramesh P, et al.
Publicado: (2020) -
Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker
por: Yu, Wei, et al.
Publicado: (2016) -
SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer
por: Yu, Wei, et al.
Publicado: (2017) -
Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men
por: Farrell, James, et al.
Publicado: (2013)